
VIOV, the Vanguard small-cap value ETF, tracks 600 cheap U.S. stocks. The factor tilt has drawn inflows as growth names sell off, but a recession would test the portfolio.
The Vanguard S&P Small-Cap 600 Value Index Fund ETF (VIOV) tracks a slice of the U.S. small-cap market that screens for low price-to-book, low price-to-earnings, and other value metrics. That factor tilt sets it apart from broad small-cap funds, and in recent weeks the difference has been visible.
VIOV holds about 600 stocks, the cheapest half of the S&P SmallCap 600 by value scores. Regional banks, insurers, and industrial distributors make up a chunk of the portfolio. Those sectors have not cratered as earnings expectations held up relative to growth names. The ETF's expense ratio sits at 0.15% – low for a passive fund with this many holdings.
Value as a factor tends to lag during momentum-driven rallies and catch up when the market reprices risk. The current selloff in technology and high-multiple names has renewed interest in that cycle. Several fund flows reports for January showed net inflows into small-cap value ETFs, VIOV among them, while growth funds saw outflows.
The key question for holders is whether the value rotation has legs. If earnings for small-cap value stocks continue to hold up while growth expectations get cut, VIOV could see continued support. A turn in the dollar or a drop in Treasury yields would tend to favor these names. On the flip side, a recession that hits bank earnings and consumer cyclicals would pressure the index.
VIOV's structure is straightforward – no leverage, no derivatives, daily rebalancing. The risk is not in the wrapper but in the cycle. For now, the ETF is doing what it is designed to do: deliver the returns of cheap small-cap stocks when cheap small-cap stocks are in favor.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.